We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
-1.67%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$100B
AUM Growth
-$8.74B
Cap. Flow
-$1.7B
Cap. Flow %
-1.7%
Top 10 Hldgs %
9.77%
Holding
2,893
New
146
Increased
1,494
Reduced
995
Closed
170

Sector Composition

Rank Sector Weight
1 Technology 16.9%
2 Industrials 13.89%
3 Financials 12.91%
4 Consumer Discretionary 10.69%
5 Healthcare 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WGS icon
2576
GeneDx Holdings
WGS
$2.32B
$46K ﹤0.01%
655
+315
+93% +$35K
PRTY
2577
DELISTED
Party City Holdco Inc.
PRTY
$46K ﹤0.01%
14,921
-22,112
-60% -$100K
NRDY icon
2578
Nerdy
NRDY
$93.5M
$45K ﹤0.01%
12,056
-344
-3% -$1.53K
RIGL icon
2579
Rigel Pharmaceuticals
RIGL
$778M
$45K ﹤0.01%
1,887
-29
-2% -$785
CECO icon
2580
Ceco Environmental
CECO
$4.11B
$43K ﹤0.01%
7,832
-125
-2% -$730
IBRX icon
2581
ImmunityBio
IBRX
$7.94B
$43K ﹤0.01%
11,816
+248
+2% +$1.52K
BKCC
2582
DELISTED
BlackRock Capital Investment Corporation
BKCC
$43K ﹤0.01%
10,463
-298
-3% -$1.23K
SNCE
2583
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$42K ﹤0.01%
535
-107
-17% -$16.8K
XERS icon
2584
Xeris Biopharma Holdings
XERS
$1.46B
$41K ﹤0.01%
16,817
+852
+5% +$2.08K
OWLT icon
2585
Owlet
OWLT
$158M
$40K ﹤0.01%
764
-92
-11% -$3.17K
NPKI
2586
NPK International
NPKI
$1.15B
$40K ﹤0.01%
11,495
-1,121
-9% -$4.17K
XXII
2587
22nd Century Group
XXII
$1.5M
0
CLVS
2588
DELISTED
Clovis Oncology, Inc.
CLVS
$38K ﹤0.01%
18,912
+1,138
+6% +$2.23K
STON
2589
DELISTED
StoneMor Inc.
STON
$38K ﹤0.01%
16,031
-456
-3% -$1.17K
MRSN
2590
DELISTED
Mersana Therapeutics
MRSN
$36K ﹤0.01%
+410
New +$47.9K
OCUL icon
2591
Ocular Therapeutix
OCUL
$2.03B
$36K ﹤0.01%
10,187
-289
-3% -$1.6K
INSG icon
2592
Inseego
INSG
$87.7M
$34K ﹤0.01%
1,190
+43
+4% +$1.97K
VSTM icon
2593
Verastem
VSTM
$615M
$34K ﹤0.01%
2,018
-58
-3% -$999
DOMA
2594
DELISTED
Doma Holdings, Inc.
DOMA
$33K ﹤0.01%
713
-19
-3% -$1.52K
ML
2595
DELISTED
MoneyLion Inc.
ML
$33K ﹤0.01%
530
-7
-1% -$546
VLTA
2596
DELISTED
Volta Inc.
VLTA
$33K ﹤0.01%
15,829
-452
-3% -$2.17K
MBT
2597
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$33K ﹤0.01%
240,364
+140,946
+142% +$1.05M
ARAY icon
2598
Accuray
ARAY
$34.9M
$32K ﹤0.01%
12,199
-102
-0.8% -$380
REX icon
2599
REX American Resources
REX
$1.43B
$31K ﹤0.01%
1,896
-8,832
-82% -$143K
BODI icon
2600
The Beachbody Company
BODI
$74M
$31K ﹤0.01%
376
-11
-3% -$1.12K

Similar funds

Victory Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Victory Capital Management held 2,893 positions worth $100B, down 8% from $109B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Victory Capital Management's Q1 2022 filing shows 146 new, 1,494 increased, 995 reduced and 170 closed positions. Its largest new stake was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.49B.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Victory Capital Management's largest Q1 2022 buy was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M.
  • Victory Capital Management added most to MKS Inc in Q1 2022, an estimated $219M increase.
  • Victory Capital Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.49B.
  • Victory Capital Management fully exited Vanguard Total World Stock ETF in Q1 2022, selling an estimated $476M.
  • Victory Capital Management's ten largest holdings make up 9.8% of its $100B portfolio in Q1 2022.
  • Victory Capital Management opened 146 new positions and closed 170 in Q1 2022.
  • Victory Capital Management's portfolio value fell 8% quarter-over-quarter to $100B.

Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.